Rivaroxaban and Risk of Venous Thromboembolism in Patients With Symptomatic Peripheral Artery Disease After Lower Extremity Revascularization
Author(s) -
Connie N. Hess,
Michael Szarek,
Sonia S. Anand,
Rupert Bauersachs,
Manesh R. Patel,
E. Sebastian Debus,
Mark R. Nehler,
Warren H. Capell,
Joshua A. Beckman,
Gregory Piazza,
Stanislav Henkin,
A. Bura-Rivière,
Holger Lawall,
K Roztocĭl,
Judith Hsia,
Eva Muehlhofer,
Scott D. Berkowitz,
Lloyd Haskell,
Marc P. Bonaca
Publication year - 2022
Publication title -
jama network open
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.278
H-Index - 39
ISSN - 2574-3805
DOI - 10.1001/jamanetworkopen.2022.15580
Subject(s) - medicine , rivaroxaban , arterial disease , revascularization , venous thromboembolism , peripheral , cardiology , vascular disease , thrombosis , warfarin , myocardial infarction , atrial fibrillation
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom